APA (7th ed.) Citation

J, C., G, W., Y, W., EM, C., T, W., D, S., . . . DA, W. (2021). Discovery of BMS-986318, a Potent Nonbile Acid FXR Agonist for the Treatment of Nonalcoholic Steatohepatitis. ACS medicinal chemistry letters, 12(9), 1413. https://doi.org/10.1021/acsmedchemlett.1c00198

Chicago Style (17th ed.) Citation

J, Carpenter, et al. "Discovery of BMS-986318, a Potent Nonbile Acid FXR Agonist for the Treatment of Nonalcoholic Steatohepatitis." ACS Medicinal Chemistry Letters 12, no. 9 (2021): 1413. https://doi.org/10.1021/acsmedchemlett.1c00198.

MLA (9th ed.) Citation

J, Carpenter, et al. "Discovery of BMS-986318, a Potent Nonbile Acid FXR Agonist for the Treatment of Nonalcoholic Steatohepatitis." ACS Medicinal Chemistry Letters, vol. 12, no. 9, 2021, p. 1413, https://doi.org/10.1021/acsmedchemlett.1c00198.